COVID-19 Vaccine Efficacy in Solid Organ Transplant Recipients

COVID-19 Vaccine Efficacy in Solid Organ Transplant Recipients is organized by Connect Educate Impact (CEI).

Initial Release Date: August 11, 2021
Planned Expiration Date: August 11, 2024

Description:
We're one step closer to ending the COVID-19 pandemic because of vaccines. And while their efficacy and safety have been established in the general population, recent data in solid organ transplant patients raise concerns. This month's Journal Club reviews this new data on the SARS-CoV-2 mRNA vaccines in solid organ transplant recipients.

Objectives:
Upon successful completion of this application-based course, pharmacists and pharmacy students should be able to:
• Compare and contrast the morbidity and mortality associated with COVID-19 in the solid organ transplant population to that of the general population.
• Explain why patients on immunosuppression have a weakened response to vaccines.
• Analyze the current evidence on the safety and efficacy of the SARS-CoV-2 mRNA vaccine in solid organ transplant patients.
• Identify opportunities for future research endeavors evaluating the SARS-CoV-2 mRNA vaccines in solid organ transplant recipients.
• Develop a recommendation for COVID-19 vaccination in solid organ transplant recipients.

0.1 CEU